Key Insights from the Upcoming Neonatology Conference
The Hot Topics in Neonatology Conference 2024, an event that gathers experts from around the globe, will prominently feature a symposium on the clinical impact and cost savings associated with an Exclusive Human Milk Diet (EHMD). This promising approach has shown positive outcomes for extremely ill and premature infants since its inception.
Dr. Jenny Fox's Significant Contributions
Dr. Jenny Fox from Children's Hospital at Virginia Commonwealth University will offer a remarkable presentation about her firsthand experiences and the published data supporting EHMD adoption. Her insights will be drawn from two key studies that highlight the benefits of human milk-based nutritional products.
Transformational Findings Presented
During her session, Dr. Fox will delve into transformative findings that illustrate the real-world impact of EHMD on infant health. Key takeaways from her presentation include a meta-analysis showcasing a dramatic 50% reduction in mortality rates among preterm infants who were fed human milk-based nutritional products.
Cost Savings for Hospitals
The second crucial aspect of her findings involves substantial cost savings for hospitals that implement EHMD protocols. A peer-reviewed report co-authored by Dr. Fox has indicated that hospitals can save between $500,000 and $3.4 million annually after integrating these practices into their care plans for preterm infants.
Prolacta Bioscience's Role in Neonatal Care
Leading this innovative approach is Prolacta Bioscience, a company renowned for its dedication to advancing human milk science to improve health outcomes for vulnerable newborns. Over the years, Prolacta has reached a milestone where its human milk-based fortifiers are being utilized in over half of the Level III and IV neonatal intensive care units (NICUs) across the nation.
The Importance of Human Milk in NICUs
This significant utilization underscores the critical need for human milk in reducing complications, particularly the dangers of necrotizing enterocolitis (NEC), a serious intestinal condition that can affect premature infants. Human milk not only provides essential nutrients but also plays a vital role in enhancing the overall health of these infants.
Clinical Data Supporting EHMD
Dr. Fox’s enthusiasm is echoed by healthcare professionals like Dr. Melinda Elliott, chief medical officer at Prolacta, who emphasizes that the benefits of an Exclusive Human Milk Diet extend beyond individual cases to a broader impact across numerous NICUs nationwide. The positive data indicates a clear pathway for enhancing patient care while also improving hospital performance.
The Importance of Attending the Conference
Clinicians attending the conference will have the invaluable opportunity to learn directly from experts like Dr. Fox. Understanding the clinical impacts and the economic implications of EHMD can empower more healthcare providers to adopt similar practices that reinforce better outcomes for their patients.
About Prolacta Bioscience
Prolacta Bioscience is a pioneering life sciences company firmly committed to advancing the science of human milk. With operations that uphold unmatched quality and safety standards through stringent testing procedures, Prolacta has positively impacted over 100,000 premature infants globally. This evolution in neonatal care exemplifies how a concerted focus on human milk can transform health outcomes in the most vulnerable populations.
Frequently Asked Questions
What will Dr. Jenny Fox discuss at the conference?
Dr. Fox will share insights about the effectiveness and implementation of Exclusive Human Milk Diet protocols in neonatal care.
Why is an Exclusive Human Milk Diet important?
An Exclusive Human Milk Diet significantly improves health outcomes and reduces the risk of mortality among preterm infants.
What are the expected cost savings from adopting EHMD?
Hospitals can save between $500,000 to $3.4 million yearly by implementing EHMD protocols.
How has Prolacta contributed to neonatal care?
Prolacta has introduced human milk-based nutritional products in NICUs, enhancing care for premature infants.
Where can I learn more about Prolacta's products?
For more information about Prolacta and its products, visit their official website and explore their impactful research.
